Georgetown University CRS (GU CRS) (1008) — Washington D.C., District of Columbia

Georgetown University CRS (GU CRS) (1008) is a clinical research site located in Washington D.C., District of Columbia, United States 20007.

Crixeo Health Trust Score: 60/100 (FAIR). This profile has not yet been claimed by the site owner.

Georgetown University CRS (GU CRS) (1008) has participated in 7 clinical trials.

Therapeutic areas: HIV Infections, HIV-1 Infection.

Sponsors: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections.

Sponsor Feasibility Report

Trust Score: 60/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Georgetown University CRS (GU CRS) (1008)?

Georgetown University CRS (GU CRS) (1008) has a Crixeo Trust Score of 60/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Georgetown University CRS (GU CRS) (1008) conducted?

Georgetown University CRS (GU CRS) (1008) has 7 clinical trials on record. Their work covers HIV Infections, HIV-1 Infection.

Is Georgetown University CRS (GU CRS) (1008) accredited by Crixeo Health?

Georgetown University CRS (GU CRS) (1008) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Georgetown University CRS (GU CRS) (1008)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.